Company News

Myocardial Solutions Has Five Abstracts Presented at CMR 2018

February 4, 2018
Company News

BARCELONA, SPAIN, February 4, 2018 – Five abstracts utilizing Myocardial Solutions’ MyoStrain® were presented at CMR 2018: The Joint EuroCMR / SCMR Meeting in Barcelona, Spain. The conference took place in Barcelona, Spain from January 31 – February 3, 2018.

The papers span a variety of subjects including MyoStrain’s reliability, reproducibility and speed. The abstracts represent studies from the University of Chicago, Ohio State University, the Berlin Heart Institute, and the University of Bonn.

Links and/or details to the abstracts are provided below:

Title: Real-time assessment of myocardial deformation: the intra- and inter-observer agreement of LV strain using strain-encoded CMR imaging

Citation: Lapinskas T, et al. Real-time assessment of myocardial deformation: the intra- and inter-observer agreement of LV strain using strain-encoded CMR imaging. CMR 2018. (n=18)

Title: Quantitative assessment of left ventricular volumes and function using real-time strain-encoded CMR imaging: method agreement analysis

Citation: Lapinskas T, et al. Quantitative assessment of left ventricular volumes and function using real-time strain-encoded CMR imaging: method agreement analysis. CMR 2018.

Title: Reproducibility of Regional and Global Longitudinal Strain Measurements Made Using Single Beat Strain-Encoded CMR

Citation: Goyal N, et al. Reproducibility of Regional and Global Longitudinal Strain Measurements Made Using Single Beat Strain-Encoded CMR. CMR 2018. (n=15)

Title: Should Left Ventricular Global Longitudinal Strain Replace Ejection fraction as the Preferred Measurement to Quantify Left Ventricular Systolic Function?

Citation: Volpato V, et al. Should Left Ventricular Global Longitudinal Strain Replace Ejection fraction as the Preferred Measurement to Quantify Left Ventricular Systolic Function? CMR 2018.

Title: Strain Encoding (SENC) Using EPI Readout

Citation: Liu Y, et al. Strain Encoding (SENC) Using EPI Readout. CMR 2018.

Media Contact

PR@myocardialsolutions.com
919.677.8100

About Myocardial Solutions, Inc.

Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.

To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.  

808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100

© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM 
Score are among the trademarks of Myocardial Solutions.